In-Vitro Diagnostics Market Latest Technology, Emerging Technology till 2027 - PowerPoint PPT Presentation

About This Presentation
Title:

In-Vitro Diagnostics Market Latest Technology, Emerging Technology till 2027

Description:

The in-vitro diagnostics market was valued at US$ 63,746.63 million in 2019 and it is projected to reach US$ 90,656.80 million by 2027; it is expected to grow at a CAGR of 4.5% from 2020 to 2027. – PowerPoint PPT presentation

Number of Views:5

less

Transcript and Presenter's Notes

Title: In-Vitro Diagnostics Market Latest Technology, Emerging Technology till 2027


1
In-Vitro Diagnostics Market Global Trends, Size,
Segments and Growth till 2027
  • Published Date May 2022

Email sales_at_theinsightpartners.com
2
Report Studies
Email sales_at_theinsightpartners.com
  • In-Vitro Diagnostics Market Forecast to 2027 -
    COVID-19 Impact and Global Analysis By Product
    and Services (Reagents and Kits, Instruments, and
    Software and Services), Technology
    (Immunoassay/Immunochemistry, Clinical Chemistry,
    Molecular Diagnostics, Microbiology, Blood
    Glucose Self-Monitoring, Coagulation
    Hemostasis, Hematology, Urinalysis, and Others),
    Application (Infectious Diseases, Diabetes,
    Oncology, Cardiology, Autoimmune Diseases,
    Nephrology, and Others), and End User (Hospitals,
    Laboratories, Homecare, and Others), and
    Geography

3
In-Vitro Diagnostics Market Overview
Email sales_at_theinsightpartners.com
  • The In-vitro Diagnostics Market was valued at US
    63,746.63 million in 2019 and it is projected to
    reach US 90,656.80 million by 2027 it is
    expected to grow at a CAGR of 4.5 from 2020 to
    2027.
  •  The market is estimated to grow at a CAGR of
    4.5 from 2020 to 2027. The report highlights the
    trends prevalent in the global in-vitro
    diagnostics market and the factors driving the
    market along with those that act as deterrents to
    its growth. In terms of product services, the
    in-vitro diagnostics market is segmented into
    instruments, reagents kits, and software
    services. In 2019, the reagents kits segment
    held a largest market share of the in-vitro
    diagnostics market. This segment is also expected
    to dominate the market during the forecast period
    owing to increasing number of diagnostics tests
    and rising prevalence of chronic conditions.

4
Key Segment Market
Email sales_at_theinsightpartners.com
  • Segment By Type-
  • By Product (Reagents Kits, Instruments,
    Software Services and Others)
  • Application (Infectious Diseases, Diabetes,
    Oncology, Cardiology, Autoimmune Diseases,
    Nephrology, Others)
  • End-User (Hospitals, Laboratories, Homecare,
    Others)

Download Sample
5
In-Vitro Diagnostics Market Value
Email sales_at_theinsightpartners.com
  • CAGR of 4.5
  • (2020 - 2027)

Download Sample
6
Company Profiles
Email sales_at_theinsightpartners.com
  • F. Hoffmann-la Roche Ltd.
  • Danaher
  • Abbott
  • Siemens AG
  • Sysmex Corporation
  • Thermo Fisher Scientific, Inc.
  • BD
  • Biomérieux SA
  • Bio-Rad Laboratories, INC.
  • Qiagen

Download Sample
7
By Geography
Email sales_at_theinsightpartners.com
  • North America (the US, Canada, and Mexico)
  • Europe (the UK, Germany, France, Italy, Spain,
    and the Rest of Europe)
  • Asia Pacific (China, Japan, India, Australia,
    South Korea, and the Rest of Asia Pacific)
  • Middle East Africa (the UAE, Saudi Arabia,
    South Africa, and the Rest of Middle East
    Africa)
  • South Central America (Brazil, Argentina, and
    the Rest of South Central America).

8
THANKYOU!
  • Phone  1-646-491-9876
  • E-Mail sales_at_theinsightpartners.com
Write a Comment
User Comments (0)
About PowerShow.com